Literature DB >> 29501520

The Frequency and Clinical Features of Hypersensitivity Reactions to Antiepileptic Drugs in Children: A Prospective Study.

Hakan Guvenir1, Emine Dibek Misirlioglu1, Ersoy Civelek1, Muge Toyran1, Betul Buyuktiryaki1, Tayfur Ginis1, Murat Capanoglu1, Esra Gurkas2, Alev Guven2, Can Naci Kocabas3.   

Abstract

BACKGROUND: Antiepileptic drugs (AEDs) can cause hypersensitivity reactions during childhood. Studies report a wide clinical spectrum of reactions with AED use, ranging from a mild rash to severe cutaneous reactions.
OBJECTIVE: To determine the prevalence and clinical features of AED hypersensitivity reactions during childhood.
METHODS: Patients in our pediatric neurology clinic who were prescribed an AED for the first time between November 2015 and November 2016 were monitored and those who developed skin rash during this period were evaluated.
RESULTS: A total of 570 patients were evaluated. The median age of the patients was 8.86 (interquartile range, 4.2-13.7) years, and 55.8% (318) of patients were male. The most frequently used AEDs were valproic acid (42%, n = 285) and carbamazepine (20.4%, n = 116). Hypersensitivity reactions to AEDs developed in 5.4% of patients. Of these patients, 71% (29) had cutaneous drug reactions and 29% (9) had severe cutaneous drug reactions; 61.3% (19) were using aromatic AEDs, and the leading suspected AED was carbamazepine (45.2%). Comparison of patients who did and did not develop AED hypersensitivity showed that hypersensitivity was more frequent among patients who were younger than 12 years, who used aromatic AEDs, or who used multiple AEDs. In addition, according to regression analysis results, aromatic AED use significantly increased the risk of AED hypersensitivity (P < .001).
CONCLUSIONS: Although allergic reactions to AEDs are rare, they are of significance because they can cause life-threatening severe cutaneous drug reactions. Therefore, patients receiving AEDs, especially aromatic AEDs, must be monitored closely.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiepileptic drugs; Child; DRESS; Epilepsy; Hypersensitivity; Patch test; SJS

Mesh:

Substances:

Year:  2018        PMID: 29501520     DOI: 10.1016/j.jaip.2018.02.018

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  4 in total

1.  Slow graded reintroduction of oxcarbazepine for delayed maculopapular eruption.

Authors:  Christine R F Rukasin; Elizabeth J Phillips; Allison E Norton
Journal:  Ann Allergy Asthma Immunol       Date:  2019-06-12       Impact factor: 6.347

2.  Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.

Authors:  Hyun Kyung Kim; Dae Yeon Kim; Eun Kee Bae; Dong Wook Kim
Journal:  J Korean Med Sci       Date:  2020-02-03       Impact factor: 2.153

3.  Patterns of Antiepileptic Drug Reactions in Children: A Multicenter Study.

Authors:  Parinaz Sedighi; Neda Khalili; Nastaran Khalili; Amin Doosti-Irani; Atefeh Moradi; Samira Moghadam; Meshkat Nemati; Sobhan Mohammadi Jorjafki; Reza Shervin Badv; Iraj Sedighi
Journal:  Iran J Child Neurol       Date:  2022-07-16

4.  Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy.

Authors:  Lingyan Yu; Zhiliang Wang; Zhenwei Yu; Jianhua Feng; Haibin Dai
Journal:  Ann Clin Transl Neurol       Date:  2021-06-28       Impact factor: 4.511

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.